semaglutide effects on kidneys Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial Notable Articles of 2024: FLOW

Orforglipron Reduces Body Weight in HFD-Induced Humanized GLP-1R Mice B-hGLP1R mice plus were fed a high-fat diet (HFD) to induce obesity, followed by oral Orforglipron treatment

Theres no need to find a fax machine or visit a post office

Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA

Building on the understanding that GLP-1 agonists induce weight loss through appetite suppression and slowed gastric emptying, it is crucial to recognize the potential downstream consequences of these mechanisms, particularly regarding nutritional status

For patients who are serious about losing weight in 2025, MEDVi stands out as one of the most effective and convenient options available

Semaglutide has transformed weight loss treatment, but the question of duration matters